Healthcare Division Sales Aid Bayer Financial Results

Despite achieving a net profit of US$208mn in Q409, up by 44% from Q408, German drugmaker Bayer has posted full-year 2009 sales of US$42.47bn, a 5.3% decline in revenues from the US$44.86bn earned in the previous year. The company also recorded a 20.9% decline in net income to US$1.85bn. The company missed its target of restricting the decline in earnings before interest, taxes, depreciation and amortisation (EBITDA) before special items to 5%, with EBITDA falling 6.6% during the year to US$8.82bn. Charges related to the integration of Schering, restructuring measures and litigation costs reduced earnings by US$1.04bn in

To read the full article, please choose one of the following options: